 |
 |
| Duke Oncologist Discusses Targeted Therapies and Personalized Medicine |
| How do we match the right therapy for the right individual? |
|
 |
 |
| Biomarker Found for Hepatitis C, A Precursor to Liver Cancer |
| Treatment for liver cancer or hepatitis C typically involves a difficult 48 weeks of interferon, a type of proteins than can fight hepatitis C plus the antiviral drug ribavirin. |
|
 |
 |
| Duke Researchers Develop Tool to Improve Patient-Physician Communication |
| Duke Cancer Institute researcher and nationally-recognized palliative care. . . |
|
|
|
